FIGURE 4 - uploaded by Lucile Butruille
Content may be subject to copyright.
| Alteration of gonadal functions after central GCV administration in Tg mice. Tg+GCV male mice display decreased testicular weight (A) and plasma testosterone concentrations after hCG (human chorionic gonadotropin) injection (B). Testicular histology of WT ctr (C), WT+GCV (D), Tg ctr (E) and Tg+GCV (F) male mice revealed alterations and vacuolization of seminiferous tubules after central GCV administration in Tg mice, scale bars, 50 µm Insets show a higher magnification image of a single seminiferous tube for each group of mice. Scale bar, 200 µm. Tg+GCV male mice display decreased serum LH concentration (G) while serum FSH concentration is not affected by the treatment (H). Data are expressed as the mean ± SEM, n≥3 for each group. *p<0.05, **p<0.01, ***p<0.001.

| Alteration of gonadal functions after central GCV administration in Tg mice. Tg+GCV male mice display decreased testicular weight (A) and plasma testosterone concentrations after hCG (human chorionic gonadotropin) injection (B). Testicular histology of WT ctr (C), WT+GCV (D), Tg ctr (E) and Tg+GCV (F) male mice revealed alterations and vacuolization of seminiferous tubules after central GCV administration in Tg mice, scale bars, 50 µm Insets show a higher magnification image of a single seminiferous tube for each group of mice. Scale bar, 200 µm. Tg+GCV male mice display decreased serum LH concentration (G) while serum FSH concentration is not affected by the treatment (H). Data are expressed as the mean ± SEM, n≥3 for each group. *p<0.05, **p<0.01, ***p<0.001.

Contexts in source publication

Context 1
... mice showed a stricking decrease in testes weight (Kruskal-Wallis, p<0.0001; Dunn's, p<0.05; Figure 4A). In addition, Tg+GCV mice showed a decline in the weight of preputial glands which produce pheromones . ...
Context 2
... a human chorionic gonadotropin (hCG) injection, a stimulation that elicits the release of the total testosterone content from the testes (36), a significant decrease of about 50% of the mean plasma testosterone levels was observed in Tg+GCV compared to control groups (Kruskal-Wallis, p=0.04, Dunn's, p<0.05; Figure 4B). Anatomical analysis of the testes sections showed that the three control groups, i.e. ...
Context 3
... analysis of the testes sections showed that the three control groups, i.e. WT ctr ( Figure 4C), WT+GCV ( Figure 4D) and Tg ctr ( Figure 4E), had normal seminiferous tubules. In contrast, the GCV treatment resulted in severe morphological alterations including vacuolization of seminiferous epithelium and no visible spermatozoa in the tube lumen in the Tg+GCV male mice ( Figure 4F). ...
Context 4
... analysis of the testes sections showed that the three control groups, i.e. WT ctr ( Figure 4C), WT+GCV ( Figure 4D) and Tg ctr ( Figure 4E), had normal seminiferous tubules. In contrast, the GCV treatment resulted in severe morphological alterations including vacuolization of seminiferous epithelium and no visible spermatozoa in the tube lumen in the Tg+GCV male mice ( Figure 4F). ...
Context 5
... analysis of the testes sections showed that the three control groups, i.e. WT ctr ( Figure 4C), WT+GCV ( Figure 4D) and Tg ctr ( Figure 4E), had normal seminiferous tubules. In contrast, the GCV treatment resulted in severe morphological alterations including vacuolization of seminiferous epithelium and no visible spermatozoa in the tube lumen in the Tg+GCV male mice ( Figure 4F). ...
Context 6
... ctr ( Figure 4C), WT+GCV ( Figure 4D) and Tg ctr ( Figure 4E), had normal seminiferous tubules. In contrast, the GCV treatment resulted in severe morphological alterations including vacuolization of seminiferous epithelium and no visible spermatozoa in the tube lumen in the Tg+GCV male mice ( Figure 4F). Interestingly, the seminiferous tubules of Tg+GCV mice only contained Sertoli cells, spermatogonia and some spermatocytes. ...
Context 7
... Figure 3). Moreover, no Gfap expression was detected in the testes of the control mice (data not shown) and the expression of the tk gene was undetectable in testes of Tg mice as shown by RT-PCR (Supplementary Figure 4), indicating that the anatomical defects observed in the testes were not due to a direct peripheral effect of GCV. These findings demonstrate that central GCV administration in Tg mice leads to a rapid and profound disruption of spermatogenesis and severe degradation of the testicular morphology. ...
Context 8
... there is a great variability because LH is secreted in a pulsatile and irregular manner, a significant decrease in the mean serum LH concentrations was observed in Tg+GCV male mice, (Kruskal-Wallis, p=0.04; Dunn's, p<0.05; Figure 4G) compared to control groups except for WT+GCV mice. In contrast, no significant differences were found in the mean levels of FSH, which regulate Sertoli cell function between the four groups (KruskalWallis, p>0.05; Figure 4H). ...
Context 9
... p<0.05; Figure 4G) compared to control groups except for WT+GCV mice. In contrast, no significant differences were found in the mean levels of FSH, which regulate Sertoli cell function between the four groups (KruskalWallis, p>0.05; Figure 4H). Together these data strongly suggest that 4 weeks of i.c.v. ...

Citations

... We have recently shown that ablation of dividing NSCs expressing GFAP induces a decrease in hypothalamic neurogenesis in vitro, alters the integrity of αand β-tanycytes throughout the MBH and causes hypogonadotropic hypogonadism in vivo [33], highlighting the critical role of GFAP-expressing tanycytes in hypothalamic neurogenesis and reproduction [33]. Future investigations are warranted to elucidate the role of the parenchymal GFAP-expressing cells. ...
... We have recently shown that ablation of dividing NSCs expressing GFAP induces a decrease in hypothalamic neurogenesis in vitro, alters the integrity of αand β-tanycytes throughout the MBH and causes hypogonadotropic hypogonadism in vivo [33], highlighting the critical role of GFAP-expressing tanycytes in hypothalamic neurogenesis and reproduction [33]. Future investigations are warranted to elucidate the role of the parenchymal GFAP-expressing cells. ...
... Tanycytes are proposed to have systemic anti-aging properties, possibly via their release of exosomal miRNAs into the CSF and/or their stem cell capacity [171]. These complex and interesting cells also regulate the bloodhypothalamic barrier and interact with the pituitary and thyroid gland in the regulation of core hypothalamic functions, including reproduction in males and females, metabolism, food/water intake and aggression [172][173][174][175]. ...
Article
Full-text available
The conceptualization of polycystic ovary syndrome (PCOS) has primarily focused on hormonal alterations driven by changes within the hypothalamus and ovarian granulosa cells, with treatment by the contraceptive pill and weight loss. However, a growing body of data implicates wider systemic and central nervous system (CNS) changes in the pathoetiology and pathophysiology of PCOS, with consequent implications for targeted treatments. It is proposed that there is a significant role for night-time interactions of factors acting to regulate whether the rising level of cortisol over the night and during the morning cortisol awakening response (CAR) is able to induce the nuclear translocation of the glucocorticoid receptor (GR), thereby influencing how the immune and glial systems regulate cellular function in preparation for the coming day. Factors affording protection in PCOS also inhibit GR nuclear translocation including gut microbiome-derived butyrate, and pineal/local melatonin as well as melatonin regulated bcl2-associated athanogene (BAG)-1. A significant pathophysiological role in PCOS is attributed to the aryl hydrocarbon receptor (AhR), which shows heightened levels and activity in PCOS. The AhR is activated by ligands of many systemic processes, including white adipocyte-derived kynurenine, implicating obesity in the pathophysiological changes occurring in the hypothalamus and ovaries. AhR activation has consequences for the physiological function in the hypothalamic paraventricular nucleus, granulosa cells and adipocytes, partly mediated by AhR upregulation of the mitochondrial N-acetylserotonin/melatonin ratio, thereby decreasing melatonin availability whilst increasing local stress plasticity in the paraventricular nucleus. This article reviews in detail the wider systemic and CNS changes in PCOS highlighting interactions of local and pineal melatonergic pathway, gut microbiome-derived butyrate, white adipocyte-derived kynurenine, the hypothalamic paraventricular nucleus tanycytes/astrocytes, and the hypothalamus-pituitary-adrenal (HPA) axis driven glucocorticoid receptor activation in PCOS pathophysiology. This integrates a wide array of previously disparate data on the biological underpinnings of PCOS, including how PCOS associates with many other currently classified medical conditions, such as depression, bipolar disorder, type 1 diabetes mellitus and the autism spectrum. Numerous future research and treatment implications are detailed. Keywords: polycystic ovary syndrome; depression; gut microbiome; melatonin; N-acetylserotonin; aryl hydrocarbon receptor; kynurenine; tanycytes; paraventricular nucleus; adipocytes; treatment; tyrosine kinase receptor B